Evidence map›Paper›PMID 40095173›Full record

ArticleJournal of community health2025

Naloxone Acceptance among Nightclub Attendees in New York City.

Nina Abukahok, Patricia Acosta, Amanda M Bunting, Joseph J Palamar

Abstract read
In one paragraph

Article in Journal of community health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nina AbukahokDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA. nina.abukahok@nyulangone.org.ORCID 0009-0008-7079-2003
Patricia AcostaDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
Amanda M BuntingDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-2103-9655
Joseph J PalamarDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA.

Funding

New psychoactive substance exposure among NYC nightclub and festival attendeesR01DA057289 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Joseph J Palamar · 2023 to 2026
$2.7M
Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and EffectsR01DA060207 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Joseph J Palamar · 2024 to 2026
$2.1M
NIDA NIH HHS 23-A1-00-1008299NIDA NIH HHS R01 DA057289NIDA NIH HHS R01 DA060207
6 · The paper itself

Abstract

As the opioid crisis continues, now driven by use of fentanyl, naloxone is an increasingly important intervention to reverse overdoses. More research is needed on the willingness of populations at risk for unintentional fentanyl exposure (through adulterated drugs) to accept naloxone to reverse potential overdoses. Adults (n = 991) entering randomly selected nightclubs in New York City (NYC) were surveyed at the point-of-recruitment in 2024 and were asked about their willingness to accept a free naloxone kit. We examined the prevalence of reported willingness to accept naloxone and reasons for refusal, and we examined prevalence and correlates of participants accepting naloxone. During the survey, 65.2% of participants reported being familiar with naloxone, 62.1% agreed to accept naloxone, and 49.6% were recorded as accepting a kit. Those residing in NYC, compared to visitors, had a higher prevalence of recorded acceptance (aPR = 1.41, 95% CI: 1.11-1.79), as did those reporting familiarity with naloxone (aPR = 1.27, 95% CI: 1.02-1.58), and those with an average higher readiness to intervene in an opioid overdose (aPR = 1.18, 95% CI: 1.04-1.33). The majority who refused (56.1%) reported not being interested; 10.1% reported that they were not worried about overdoses, and 8.2% reported that they already had naloxone. Although 83.4% agreed that naloxone is used to reverse opioid overdoses, 35.4% reportedly thought that naloxone is used to reverse the effects of cocaine or any drug. While at least half of attendees were willing to accept a naloxone kit, lack of interest and lack of knowledge about naloxone were potential barriers to carrying naloxone.

Indexed as

Drug OverdoseNaloxoneNarcotic AntagonistsPatient Acceptance of Health CareAdolescentAdultFemaleHumansMaleMiddle AgedNew York CityYoung AdultNaloxoneNarcotic AntagonistsFentanylHarm reductionNaloxoneOpioidsOverdose

Identifiers

PMID40095173
PMCPMC12303770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.